- Report
- October 2024
- 169 Pages
Global
From €2210EUR$2,325USD£1,857GBP
€4421EUR$4,650USD£3,714GBP
- Report
- March 2025
- 198 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2025
- 454 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 293 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 182 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 400 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- November 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- January 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 184 Pages
Global
From €4278EUR$4,500USD£3,594GBP

Biologics Development is a field of drug discovery that focuses on the development of biopharmaceuticals, which are drugs derived from living organisms. This includes proteins, peptides, nucleic acids, and other molecules. The process of biologics development involves the identification of a target molecule, the design of a drug to interact with the target, and the production of the drug. The development of biologics requires a deep understanding of the biology of the target molecule, as well as the ability to produce the drug in a cost-effective manner.
Biologics Development is a rapidly growing field, with many companies investing in the development of new biopharmaceuticals. Companies such as Amgen, Biogen, Genentech, and Novartis are leading the way in the development of biologics. Other companies such as AbbVie, AstraZeneca, and Merck are also investing in the development of biologics. These companies are working to develop new treatments for a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Show Less Read more